Basophilic differentiation of the human leukemia cell line KU812 upon treatment with interleukin-4

Biochem Biophys Res Commun. 1998 Jun 29;247(3):542-8. doi: 10.1006/bbrc.1998.8816.

Abstract

The human leukemia cell line KU812 had been described as an immature prebasophilic cell line and exhibits a potential to differentiate into mature basophils. We studied the effect of interleukin-4 (IL-4) on the basophilic differentiation of KU812 cells. When KU812 cells were cultured with 1 ng/ml IL-4, cellular histamine content increased more than 10-fold. IL-4 also enhanced the expression of Fc epsilon RI alpha, a high affinity IgE receptor, on the cell surface. KU812 cells treated with IL-4 expressed higher levels of Fc epsilon RI alpha, Fc epsilon RI beta and Fc epsilon RI gamma mRNA than non treated KU812 cells. After 21 days in culture with IL-4, KU812 cells became morphologically mature basophilic cells as demonstrated by staining positive for cytoplasmic granules and heparin proteoglycan by Wright dye and toluidin blue dye respectively. In addition, IgE-mediated histamine release was observed, suggesting that the Fc epsilon RI induced by IL-4 was functional and was able to transduce a signal for degranulation. These results suggest that IL-4 promotes differentiation of KU812 cells into mature basophilic cells both morphologically and functionally.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Basophils / physiology*
  • Cell Differentiation / drug effects*
  • Flow Cytometry
  • Gene Expression Regulation, Developmental / drug effects
  • Histamine Release / drug effects
  • Histocytochemistry
  • Humans
  • Immunoglobulin E / metabolism
  • Interleukin-4 / pharmacology*
  • Leukemia / metabolism
  • RNA, Messenger / metabolism
  • Receptors, IgE / metabolism
  • Tumor Cells, Cultured
  • Up-Regulation / physiology

Substances

  • RNA, Messenger
  • Receptors, IgE
  • Interleukin-4
  • Immunoglobulin E